These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 9581161)

  • 1. Use of Terazosin to Treat Trauma-Related Nightmares After a Failed Trial of Prazosin.
    White RT; Armijo CJ; Elmaoued AA
    Prim Care Companion CNS Disord; 2024 Mar; 26(2):. PubMed ID: 38442072
    [No Abstract]   [Full Text] [Related]  

  • 2. Terazosin for benign prostatic hyperplasia.
    Med Lett Drugs Ther; 1994 Feb; 36(916):15-6. PubMed ID: 7508075
    [No Abstract]   [Full Text] [Related]  

  • 3. Terazosin for BPH.
    Jerant AF
    J Fam Pract; 1995 Mar; 40(3):222-3. PubMed ID: 7533204
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe cutaneous reaction due to terazosin.
    Hernández-Cano N; Herranz P; Lázaro TE; Mayor M; Casado M
    Lancet; 1998 Jul; 352(9123):202-3. PubMed ID: 9683215
    [No Abstract]   [Full Text] [Related]  

  • 5. [Terazosin].
    Schäfers RF; Michel MC
    Dtsch Med Wochenschr; 1998 Apr; 123(15):459-60. PubMed ID: 9581161
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of terazosin hydrochloride (Hytrin) in the treatment of patients with benign prostatic hyperplasia].
    Sivkov AV; Apolikhin OI; Medvedev AA
    Urol Nefrol (Mosk); 1997; (5):50-3. PubMed ID: 9412019
    [No Abstract]   [Full Text] [Related]  

  • 7. [New in Austria approved specialty drugs and new knowledge regarding currently available specialty drugs. Uroflo].
    Wien Klin Wochenschr; 1995; 107(15):472-6. PubMed ID: 7545857
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progress in the studies of alpha1-adrenoceptor blocker for concurrent benign prostatic hyperplasia and hypertension].
    Yang MG; Zhao XK
    Zhonghua Nan Ke Xue; 2007 Sep; 13(9):830-4. PubMed ID: 17929564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Terazosine in the treatment of benign prostatic hypertrophy].
    Caine M
    J Urol (Paris); 1993; 99(6):311-3. PubMed ID: 7516376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terazosin, doxazosin, and prazosin: current clinical experience.
    Akduman B; Crawford ED
    Urology; 2001 Dec; 58(6 Suppl 1):49-54. PubMed ID: 11750252
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.